Cocrystal Pharma (COCP) Liabilities from Discontinued Operations (2012 - 2013)
Cocrystal Pharma (COCP) reported Liabilities from Discontinued Operations of 1205702.0 for Q4 2013, down 58.35% on a YoY basis from 2894579.0 in Q4 2012, and down 58.35% sequentially from 2894579.0 in Q4 2012.
Cocrystal Pharma (COCP) Liabilities from Discontinued Operations (2012 - 2013) Analysis & Trends
Cocrystal Pharma (COCP) has 2 years of Liabilities from Discontinued Operations data on file, last reported at 1205702.0 in Q4 2013.
- For the quarter ending Q4 2013, Liabilities from Discontinued Operations fell 58.35% year-over-year to 1205702.0; the trailing twelve-month figure through Dec 2013 stood at 1205702.0 (down 58.35% YoY), and the FY2013 full-year result was 1205702.0, down 58.35% from the prior year.
- Liabilities from Discontinued Operations eased to 1205702.0 in Q4 2013, from 2894579.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 2894579.0 in Q4 2012 to a low of 1205702.0 in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 1.21 Mn |
| Dec 31, 2013 | 1.21 Mn |
| Dec 31, 2012 | 2.89 Mn |
| Dec 31, 2012 | 2.89 Mn |